{"id":535,"date":"2020-10-06T15:06:21","date_gmt":"2020-10-06T07:06:21","guid":{"rendered":"https:\/\/nhkuivf.hku.hk\/?page_id=535"},"modified":"2025-07-17T16:43:37","modified_gmt":"2025-07-17T08:43:37","slug":"monogenic-diseases","status":"publish","type":"page","link":"https:\/\/hkuivf.hku.hk\/en\/services\/preimplantation-genetic-testing\/monogenic-diseases\/","title":{"rendered":"PGT-M -Preimplantation Genetic Testing for Monogenic Disease"},"content":{"rendered":"

Prevent the transfer of embryos with monogenic disorders.<\/p>\n

We have offered PGT-M since 2007 and have worked on over 130 monogenic disorders.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Disease<\/strong><\/p>\n<\/td>\n

\n

Inheritance<\/strong><\/p>\n<\/td>\n

\n

MIM no.<\/strong><\/p>\n<\/td>\n<\/tr>\n

15q11.2 deletion syndrome<\/td>\nAutosomal dominant<\/td>\n\n

615656<\/p>\n<\/td>\n<\/tr>\n

16p11.2 duplication syndrome<\/td>\nAutosomal dominant<\/td>\n\n

614671<\/p>\n<\/td>\n<\/tr>\n

16p13.11 microdeletion syndrome<\/td>\nAutosomal dominant<\/td>\n\n

261236<\/p>\n<\/td>\n<\/tr>\n

3-Methylcrotonyl-CoA carboxylase 1 deficiency<\/td>\nAutosomal recessive<\/td>\n\n

210200<\/p>\n<\/td>\n<\/tr>\n

Achondroplasia<\/td>\nAutosomal dominant<\/td>\n\n

100800<\/p>\n<\/td>\n<\/tr>\n

Aicardi-Goutieres syndrome<\/td>\nAutosomal recessive<\/td>\n\n

610329<\/p>\n<\/td>\n<\/tr>\n

Alpha-thalassemia<\/td>\nAutosomal recessive<\/td>\n\n

604131<\/p>\n<\/td>\n<\/tr>\n

Alport syndrome 1<\/td>\nX-linked dominant<\/td>\n\n

301050<\/p>\n<\/td>\n<\/tr>\n

Alport syndrome 2<\/td>\nAutosomal recessive<\/td>\n\n

203780<\/p>\n<\/td>\n<\/tr>\n

Amyotrophic lateral sclerosis 1<\/td>\nAutosomal dominant<\/td>\n\n

105400<\/p>\n<\/td>\n<\/tr>\n

Androgen Insensitivity syndrome<\/td>\nX-linked recessive<\/td>\n\n

300068<\/p>\n<\/td>\n<\/tr>\n

Anterior segment dysgenesis 3<\/td>\nAutosomal dominant<\/td>\n\n

601631<\/p>\n<\/td>\n<\/tr>\n

Aromatic L-amino acid decarboxylase deficiency<\/td>\nAutosomal recessive<\/td>\n\n

608643<\/p>\n<\/td>\n<\/tr>\n

Axenfeld-Rieger syndrome type 3<\/td>\nAutosomal dominant<\/td>\n\n

602482<\/p>\n<\/td>\n<\/tr>\n

Barth Syndrome<\/td>\nX-linked recessive<\/td>\n\n

302060<\/p>\n<\/td>\n<\/tr>\n

Becker muscular dystrophy<\/td>\nX-linked recessive<\/td>\n\n

300376<\/p>\n<\/td>\n<\/tr>\n

Beta-thalassemia<\/td>\nAutosomal recessive<\/td>\n\n

613985<\/p>\n<\/td>\n<\/tr>\n

Branchiootorenal Syndrome 1<\/td>\nAutosomal dominant<\/td>\n\n

113650<\/p>\n<\/td>\n<\/tr>\n

Breast Cancer, Familial<\/td>\nAutosomal dominant<\/td>\n\n

114480<\/p>\n<\/td>\n<\/tr>\n

Breast-ovarian cancer, familial 1<\/td>\nAutosomal dominant<\/td>\n\n

604370<\/p>\n<\/td>\n<\/tr>\n

Breast-ovarian cancer, familial, 2<\/td>\nAutosomal dominant<\/td>\n\n

612555<\/p>\n<\/td>\n<\/tr>\n

Cardiomyopathy, familial hypertrophic, 2<\/td>\nAutosomal dominant<\/td>\n\n

115195<\/p>\n<\/td>\n<\/tr>\n

Ceroid Lipofuscinosis, neuronal, 7<\/td>\nAutosomal recessive<\/td>\n\n

610951<\/p>\n<\/td>\n<\/tr>\n

Charcot-Marie-Tooth Disease<\/td>\nX-linked dominant<\/td>\n\n

302800<\/p>\n<\/td>\n<\/tr>\n

chromosome 22q11.2 deletion syndrome<\/td>\nAutosomal dominant<\/td>\n\n

188400<\/p>\n<\/td>\n<\/tr>\n

Cleidocranial Dysplasia<\/td>\nAutosomal dominant<\/td>\n\n

119600<\/p>\n<\/td>\n<\/tr>\n

Citrullinemia, type II, neonatal-onset<\/td>\nAutosomal recessive<\/td>\n\n

605814<\/p>\n<\/td>\n<\/tr>\n

Colorectal cancer, hereditary nonpolyposis, type 5 (HNPCC5)<\/td>\nAutosomal dominant<\/td>\n\n

614350<\/p>\n<\/td>\n<\/tr>\n

Colorectal cancer, hereditary nonpolyposis, type 8 (HNPCC8)<\/td>\nAutosomal dominant<\/td>\n\n

613244<\/p>\n<\/td>\n<\/tr>\n

Congenital adrenal hyperplasia<\/td>\nAutosomal recessive<\/td>\n\n

201910<\/p>\n<\/td>\n<\/tr>\n

Congenital dyserythropoietic anaemia<\/td>\nAutosomal recessive<\/td>\n\n

613673<\/p>\n<\/td>\n<\/tr>\n

Culler-Jones Syndrome<\/td>\nAutosomal dominant<\/td>\n\n

615849<\/p>\n<\/td>\n<\/tr>\n

Cyanosis, transient neonatal<\/td>\nAutosomal dominant<\/td>\n\n

613977<\/p>\n<\/td>\n<\/tr>\n

Cystic fibrosis<\/td>\nAutosomal recessive<\/td>\n\n

219700<\/p>\n<\/td>\n<\/tr>\n

Deafness, autosomal recessive 4, with enlarged vestibular aqueduct<\/td>\nAutosomal recessive<\/td>\n\n

600791<\/p>\n<\/td>\n<\/tr>\n

Diamond-Blackfan Anemia 8<\/td>\nAutosomal dominant<\/td>\n\n

612563<\/p>\n<\/td>\n<\/tr>\n

Dilated cardiomyopathy<\/td>\nAutosomal dominant<\/td>\n\n

613426<\/p>\n<\/td>\n<\/tr>\n

Dilated cardiomyopathy-1G<\/td>\nAutosomal dominant<\/td>\n\n

604145<\/p>\n<\/td>\n<\/tr>\n

Dilated Cardiomyopathy-1HH<\/td>\nAutosomal dominant<\/td>\n\n

613881<\/p>\n<\/td>\n<\/tr>\n

Distal Arthrogryposis type 2B1<\/td>\nAutosomal dominant<\/td>\n\n

601680<\/p>\n<\/td>\n<\/tr>\n

Duchenne muscular dystrophy<\/td>\nX-linked recessive<\/td>\n\n

310200<\/p>\n<\/td>\n<\/tr>\n

Ectodermal dysplasia and immunodeficiency 2<\/td>\nAutosomal dominant<\/td>\n\n

612132<\/p>\n<\/td>\n<\/tr>\n

Ehlers-Danlos syndrome, classic type<\/td>\nAutosomal dominant<\/td>\n\n

130000<\/p>\n<\/td>\n<\/tr>\n

Fabry Disease<\/td>\nX-linked<\/td>\n\n

301500<\/p>\n<\/td>\n<\/tr>\n

Familial adenomatosis polyposis 1<\/td>\nAutosomal dominant<\/td>\n\n

175100<\/p>\n<\/td>\n<\/tr>\n

Familial amyloidotic polyneuopathy<\/td>\nAutosomal dominant<\/td>\n\n

105210<\/p>\n<\/td>\n<\/tr>\n

Fetal akinesia deformation sequence 2<\/td>\nAutosomal recessive<\/td>\n\n

618388<\/p>\n<\/td>\n<\/tr>\n

Fetal hemoglobin quantitative trait locus 1<\/td>\nAutosomal dominant<\/td>\n\n

141749<\/p>\n<\/td>\n<\/tr>\n

Fragile X syndrome<\/td>\nX-linked dominant<\/td>\n\n

300624<\/p>\n<\/td>\n<\/tr>\n

GJB2-related DFNB1 nonsyndromic hearing loss and deafness<\/td>\nAutosomal recessive<\/td>\n\n

220290<\/p>\n<\/td>\n<\/tr>\n

Glutaric Aciduria type II<\/td>\nAutosomal recessive<\/td>\n\n

231680<\/p>\n<\/td>\n<\/tr>\n

Glycine Encephalopahty<\/td>\nAutosomal recessive<\/td>\n\n

605899<\/p>\n<\/td>\n<\/tr>\n

Glycogen Storage Disease Ib<\/td>\nAutosomal recessive<\/td>\n\n

232220<\/p>\n<\/td>\n<\/tr>\n

Glycogen storage disease II<\/td>\nAutosomal recessive<\/td>\n\n

232300<\/p>\n<\/td>\n<\/tr>\n

Hemophilia A<\/td>\nX-linked recessive<\/td>\n\n

306700<\/p>\n<\/td>\n<\/tr>\n

Hemophilia B<\/td>\nX-linked recessive<\/td>\n\n

306900<\/p>\n<\/td>\n<\/tr>\n

Hereditary Multiple Osteochondromas<\/td>\nAutosomal dominant<\/td>\n\n

608177<\/p>\n<\/td>\n<\/tr>\n

Hereditary Multiple Osteochondromas<\/td>\nAutosomal dominant<\/td>\n\n

133700<\/p>\n<\/td>\n<\/tr>\n

Holoprosencephaly 9<\/td>\nAutosomal dominant<\/td>\n\n

610829<\/p>\n<\/td>\n<\/tr>\n

Huntington’s Disease<\/td>\nAutosomal dominant<\/td>\n\n

143100<\/p>\n<\/td>\n<\/tr>\n

Hypertrophic cardiomyopathy I<\/td>\nAutosomal dominant<\/td>\n\n

192600<\/p>\n<\/td>\n<\/tr>\n

Hypohydrotic ectodermal dysplasia<\/td>\nX-linked recessive<\/td>\n\n

305100<\/p>\n<\/td>\n<\/tr>\n

Hypophospatasia<\/td>\nAutosomal dominant<\/td>\n\n

146300<\/p>\n<\/td>\n<\/tr>\n

Insensitivity to pain, congenital, with anhidrosis<\/td>\nAutosomal recessive<\/td>\n\n

256800<\/p>\n<\/td>\n<\/tr>\n

Joubert syndrome 17<\/td>\nAutosomal recessive<\/td>\n\n

614615<\/p>\n<\/td>\n<\/tr>\n

Kennedy disease<\/td>\nX-linked recessive<\/td>\n\n

313200<\/p>\n<\/td>\n<\/tr>\n

Leri-Weill Dyschondrosteosis<\/td>\nPseudoautosomal dominant<\/td>\n\n

127300<\/p>\n<\/td>\n<\/tr>\n

Lesch-Nyhan Syndrome<\/td>\nX-linked recessive<\/td>\n\n

300322<\/p>\n<\/td>\n<\/tr>\n

Loeys-Dietz syndrome 2<\/td>\nAutosomal dominant<\/td>\n\n

610168<\/p>\n<\/td>\n<\/tr>\n

Long QT syndrome I<\/td>\nAutosomal dominant<\/td>\n\n

192500<\/p>\n<\/td>\n<\/tr>\n

Lynch Syndrome I<\/td>\nAutosomal dominant<\/td>\n\n

120435<\/p>\n<\/td>\n<\/tr>\n

Lynch Syndrome II<\/td>\nAutosomal dominant<\/td>\n\n

609310<\/p>\n<\/td>\n<\/tr>\n

Marfan Syndrome<\/td>\nAutosomal dominant<\/td>\n\n

154700<\/p>\n<\/td>\n<\/tr>\n

MEGDEL syndrome<\/td>\nAutosomal recessive<\/td>\n\n

614739<\/p>\n<\/td>\n<\/tr>\n

Metachromatic leukodystrophy<\/td>\nAutosomal recessive<\/td>\n\n

250100<\/p>\n<\/td>\n<\/tr>\n

Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency<\/td>\nAutosomal recessive<\/td>\n\n

251000<\/p>\n<\/td>\n<\/tr>\n

microduplication \/ microdeletion of uncertain significance<\/td>\nAutosomal dominant<\/td>\n\n

NA<\/p>\n<\/td>\n<\/tr>\n

Mitochondrial Complex 1 Deficiency, nuclear type 16<\/td>\nAutosomal recessive<\/td>\n\n

618238<\/p>\n<\/td>\n<\/tr>\n

Mitochondrial Complex I deficiency<\/td>\nAutosomal recessive<\/td>\n\n

252010<\/p>\n<\/td>\n<\/tr>\n

Mitochondrial encephalopathy, lactic acidosis and stroke like (MELAS) syndrome<\/td>\nMitochondrial inheritance<\/td>\n\n

540000<\/p>\n<\/td>\n<\/tr>\n

Mitochondrial myopathy and ataxia<\/td>\nAutosomal recessive<\/td>\n\n

617675<\/p>\n<\/td>\n<\/tr>\n

Multiple Endocrine Neoplasia type I syndrome<\/td>\nAutosomal dominant<\/td>\n\n

131100<\/p>\n<\/td>\n<\/tr>\n

Multiple exostoses type II<\/td>\nAutosomal dominant<\/td>\n\n

133701<\/p>\n<\/td>\n<\/tr>\n

Muscular dystrophy, congenital<\/td>\nAutosomal recessive<\/td>\n\n

607855<\/p>\n<\/td>\n<\/tr>\n

Muscular dystrophy, limb-gridle, autosomal recessive 23<\/td>\nAutosomal recessive<\/td>\n\n

618138<\/p>\n<\/td>\n<\/tr>\n

Myasthenic syndrome congenital 11<\/td>\nAutosomal recessive<\/td>\n\n

616326<\/p>\n<\/td>\n<\/tr>\n

Myopathy Myofibrillar 5<\/td>\nAutosomal dominant<\/td>\n\n

609524<\/p>\n<\/td>\n<\/tr>\n

Myotonia congenita, atypical, acetazolamide-responsive<\/td>\nAutosomal dominant<\/td>\n\n

608390<\/p>\n<\/td>\n<\/tr>\n

Myotonic Dystrophy type 1<\/td>\nAutosomal dominant<\/td>\n\n

160900<\/p>\n<\/td>\n<\/tr>\n

Nemaline Myopathy<\/td>\nAutosomal recessive<\/td>\n\n

615348<\/p>\n<\/td>\n<\/tr>\n

Neurofibromatosis type I<\/td>\nAutosomal dominant<\/td>\n\n

162200<\/p>\n<\/td>\n<\/tr>\n

Niemann-Pick Disease Type A<\/td>\nAutosomal recessive<\/td>\n\n

257200<\/p>\n<\/td>\n<\/tr>\n

Niemann-Pick Disease Type B<\/td>\nAutosomal recessive<\/td>\n\n

607616<\/p>\n<\/td>\n<\/tr>\n

Noonan Syndrome 1<\/td>\nAutosomal dominant<\/td>\n\n

163950<\/p>\n<\/td>\n<\/tr>\n

Oculocutaneous albinism, type VIII<\/td>\nAutosomal recessive<\/td>\n\n

619165<\/p>\n<\/td>\n<\/tr>\n

Opitz\/GBBB syndrome<\/td>\nX-linked recessive<\/td>\n\n

300000<\/p>\n<\/td>\n<\/tr>\n

Orofacial cleft-6<\/td>\nAutosomal dominant<\/td>\n\n

608864<\/p>\n<\/td>\n<\/tr>\n

Osteogenesis Imperfecta<\/td>\nAutosomal dominant<\/td>\n\n

166200<\/p>\n<\/td>\n<\/tr>\n

Osteogenesis Imperfecta type III<\/td>\nAutosomal dominant<\/td>\n\n

259420<\/p>\n<\/td>\n<\/tr>\n

Osteogenesis Imperfecta type IV<\/td>\nAutosomal dominant<\/td>\n\n

166220<\/p>\n<\/td>\n<\/tr>\n

Pancreatic agenesis and congenital heart defects<\/td>\nAutosomal dominant<\/td>\n\n

600001<\/p>\n<\/td>\n<\/tr>\n

Pendred Syndrome<\/td>\nAutosomal recessive<\/td>\n\n

274600<\/p>\n<\/td>\n<\/tr>\n

Peutz-Jeghers Syndrome<\/td>\nAutosomal dominant<\/td>\n\n

175200<\/p>\n<\/td>\n<\/tr>\n

Phenylketonuria<\/td>\nAutosomal recessive<\/td>\n\n

261600<\/p>\n<\/td>\n<\/tr>\n

Pheochromocytoma<\/td>\nAutosomal dominant<\/td>\n\n

171300<\/p>\n<\/td>\n<\/tr>\n

Polycystic kidney disease, adult type I<\/td>\nAutosomal dominant<\/td>\n\n

173900<\/p>\n<\/td>\n<\/tr>\n

Propionic acidemia<\/td>\nAutosomal recessive<\/td>\n\n

606054<\/p>\n<\/td>\n<\/tr>\n

Pyridoxamine 5′-phosphate oxidase deficiency (PNPOD)<\/td>\nAutosomal recessive<\/td>\n\n

610090<\/p>\n<\/td>\n<\/tr>\n

Pyruvate kinase deficiency of red cells<\/td>\nAutosomal recessive<\/td>\n\n

266200<\/p>\n<\/td>\n<\/tr>\n

Restrictive dermopathy, lethal<\/td>\nAutosomal recessive<\/td>\n\n

275210<\/p>\n<\/td>\n<\/tr>\n

Schwannomatosis 2; SWN2<\/td>\nAutosomal dominant<\/td>\n\n

615670<\/p>\n<\/td>\n<\/tr>\n

Schwannomatosis-2<\/td>\nAutosomal dominant<\/td>\n\n

615670<\/p>\n<\/td>\n<\/tr>\n

Seizures, benign neonatal, type 2<\/td>\nAutosomal dominant<\/td>\n\n

121201<\/p>\n<\/td>\n<\/tr>\n

Sengers syndrome<\/td>\nAutosomal recessive<\/td>\n\n

212350<\/p>\n<\/td>\n<\/tr>\n

Severe Combined Immunodeficiency<\/td>\nAutosomal recessive<\/td>\n\n

601457<\/p>\n<\/td>\n<\/tr>\n

Shwachman-Diamond syndrome<\/td>\nAutosomal recessive<\/td>\n\n

260400<\/p>\n<\/td>\n<\/tr>\n

Skeletal Dysplasia<\/td>\nAutosomal dominant<\/td>\n\n

120140<\/p>\n<\/td>\n<\/tr>\n

Spinal muscular atrophy Type I<\/td>\nAutosomal recessive<\/td>\n\n

253300<\/p>\n<\/td>\n<\/tr>\n

Spinocerebella ataxia type 3<\/td>\nAutosomal dominant<\/td>\n\n

109150<\/p>\n<\/td>\n<\/tr>\n

Spinocerebellar ataxia 17<\/td>\nAutosomal dominant<\/td>\n\n

607136<\/p>\n<\/td>\n<\/tr>\n

Spinocerebellar ataxia I<\/td>\nAutosomal dominant<\/td>\n\n

164400<\/p>\n<\/td>\n<\/tr>\n

Split-hand\/foot malformation<\/td>\nAutosomal dominant<\/td>\n\n

246560<\/p>\n<\/td>\n<\/tr>\n

Spondylocostal Dysostosis 1<\/td>\nAutosomal recessive<\/td>\n\n

277300<\/p>\n<\/td>\n<\/tr>\n

Spondyloepimetaphyseal dysplasia<\/td>\nAutosomal dominant<\/td>\n\n

616583<\/p>\n<\/td>\n<\/tr>\n

Spondyloperipheral Dysplasia<\/td>\nAutosomal dominant<\/td>\n\n

271700<\/p>\n<\/td>\n<\/tr>\n

Synpolydactyly<\/td>\nAutosomal dominant<\/td>\n\n

186000<\/p>\n<\/td>\n<\/tr>\n

Thrombocytopenia 1<\/td>\nX-linked recessive<\/td>\n\n

313900<\/p>\n<\/td>\n<\/tr>\n

Thrombophilia 7 due to antithromombin III deficiency<\/td>\nAutosomal dominant<\/td>\n\n

613118<\/p>\n<\/td>\n<\/tr>\n

Tuberous Sclerosis-2<\/td>\nAutosomal dominant<\/td>\n\n

613254<\/p>\n<\/td>\n<\/tr>\n

Type II Collagen Disorders<\/td>\nAutosomal dominant<\/td>\n\n

NA<\/p>\n<\/td>\n<\/tr>\n

very long chain acyl-CoA dehydrogenase deficiency<\/td>\nAutosomal recessive<\/td>\n\n

201475<\/p>\n<\/td>\n<\/tr>\n

von Hippel Lindau disease<\/td>\nAutosomal dominant<\/td>\n\n

193300<\/p>\n<\/td>\n<\/tr>\n

Waardenburg Syndrome<\/td>\nAutosomal dominant<\/td>\n\n

193500<\/p>\n<\/td>\n<\/tr>\n

Wilson disease<\/td>\nAutosomal recessive<\/td>\n\n

277900<\/p>\n<\/td>\n<\/tr>\n

Wiskott-Aldrich Syndrome<\/td>\nX-linked recessive<\/td>\n\n

301000<\/p>\n<\/td>\n<\/tr>\n

X-linked dilated cardiomyopathy<\/td>\nX-linked<\/td>\n\n

302045<\/p>\n<\/td>\n<\/tr>\n

X-linked Juvenile Retinoschisis<\/td>\nX-linked recessive<\/td>\n\n

312700<\/p>\n<\/td>\n<\/tr>\n

Xq28 duplication<\/td>\nX-linked recessive<\/td>\n\n

NA<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Prevent the transfer of embryos with monogenic disorders. We have offered PGT-M since 2007 and have worked on over 130 monogenic disorders. Disease Inheritance MIM<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":206,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-535","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/pages\/535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/comments?post=535"}],"version-history":[{"count":7,"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/pages\/535\/revisions"}],"predecessor-version":[{"id":1270,"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/pages\/535\/revisions\/1270"}],"up":[{"embeddable":true,"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/pages\/206"}],"wp:attachment":[{"href":"https:\/\/hkuivf.hku.hk\/en\/wp-json\/wp\/v2\/media?parent=535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}